These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7890771)

  • 21. The crystal structure of recombinant human neutrophil-activating peptide-2 (M6L) at 1.9-A resolution.
    Malkowski MG; Wu JY; Lazar JB; Johnson PH; Edwards BF
    J Biol Chem; 1995 Mar; 270(13):7077-87. PubMed ID: 7706245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High- and low-affinity binding of GRO alpha and neutrophil-activating peptide 2 to interleukin 8 receptors on human neutrophils.
    Schumacher C; Clark-Lewis I; Baggiolini M; Moser B
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10542-6. PubMed ID: 1438244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monomer-dimer equilibria of interleukin-8 and neutrophil-activating peptide 2. Evidence for IL-8 binding as a dimer and oligomer to IL-8 receptor B.
    Schnitzel W; Monschein U; Besemer J
    J Leukoc Biol; 1994 Jun; 55(6):763-70. PubMed ID: 8195702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils.
    Walz A; Dewald B; von Tscharner V; Baggiolini M
    J Exp Med; 1989 Nov; 170(5):1745-50. PubMed ID: 2681518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipopolysaccharide-stimulated human monocytes secrete, apart from neutrophil-activating peptide 1/interleukin 8, a second neutrophil-activating protein. NH2-terminal amino acid sequence identity with melanoma growth stimulatory activity.
    Schröder JM; Persoon NL; Christophers E
    J Exp Med; 1990 Apr; 171(4):1091-100. PubMed ID: 2182761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Connective tissue-activating peptide-III and its derivative, neutrophil-activating peptide-2, release histamine from human basophils.
    Reddigari SR; Kuna P; Miragliotta GF; Kornfeld D; Baeza ML; Castor CW; Kaplan AP
    J Allergy Clin Immunol; 1992 Mar; 89(3):666-72. PubMed ID: 1372016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant tumor necrosis factor-alpha potentiates neutrophil degranulation in response to host defense cytokines neutrophil-activating peptide 2 and IL-8 by modulating intracellular cyclic AMP levels.
    Brandt E; Petersen F; Flad HD
    J Immunol; 1992 Aug; 149(4):1356-64. PubMed ID: 1323612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of distinct surface-expressed and intracellular CXC-chemokine receptor 2 glycoforms in neutrophils: N-glycosylation is essential for maintenance of receptor surface expression.
    Ludwig A; Ehlert JE; Flad HD; Brandt E
    J Immunol; 2000 Jul; 165(2):1044-52. PubMed ID: 10878382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutrophil-activating peptide 2 and gro/melanoma growth-stimulatory activity interact with neutrophil-activating peptide 1/interleukin 8 receptors on human neutrophils.
    Moser B; Schumacher C; von Tscharner V; Clark-Lewis I; Baggiolini M
    J Biol Chem; 1991 Jun; 266(16):10666-71. PubMed ID: 2037605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutrophil-activating intercrine secreted by porcine platelets is active without proteolytic processing.
    Yan Z; Holt JC; Stewart GJ; Niewiarowski S
    Am J Physiol; 1993 Nov; 265(5 Pt 1):C1396-404. PubMed ID: 8238487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotactic activity and receptor binding of neutrophil attractant/activation protein-1 (NAP-1) and structurally related host defense cytokines: interaction of NAP-2 with the NAP-1 receptor.
    Leonard EJ; Yoshimura T; Rot A; Noer K; Walz A; Baggiolini M; Walz DA; Goetzl EJ; Castor CW
    J Leukoc Biol; 1991 Mar; 49(3):258-65. PubMed ID: 1997632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The amino-terminal residues in the crystal structure of connective tissue activating peptide-III (des10) block the ELR chemotactic sequence.
    Malkowski MG; Lazar JB; Johnson PH; Edwards BF
    J Mol Biol; 1997 Feb; 266(2):367-80. PubMed ID: 9047370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutrophil-activating polypeptides IL-8 and NAP-2 induce identical signal transduction pathways in the regulation of lysosomal enzyme release.
    Petersen F; Van Damme J; Flad HD; Brandt E
    Lymphokine Cytokine Res; 1991 Apr; 10(1-2):35-41. PubMed ID: 1651769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemical synthesis, purification, and characterization of two inflammatory proteins, neutrophil activating peptide 1 (interleukin-8) and neutrophil activating peptide.
    Clark-Lewis I; Moser B; Walz A; Baggiolini M; Scott GJ; Aebersold R
    Biochemistry; 1991 Mar; 30(12):3128-35. PubMed ID: 2007144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel cleavage product of beta-thromboglobulin formed in cultures of stimulated mononuclear cells activates human neutrophils.
    Walz A; Baggiolini M
    Biochem Biophys Res Commun; 1989 Mar; 159(3):969-75. PubMed ID: 2522778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formation and biological properties of neutrophil activating peptide 2 (NAP-2).
    Walz A; Zwahlen R; Baggiolini M
    Adv Exp Med Biol; 1991; 305():39-46. PubMed ID: 1755378
    [No Abstract]   [Full Text] [Related]  

  • 37. cDNA cloning and expression of guinea pig neutrophil attractant protein-1 (NAP-1). NAP-1 is highly conserved in guinea pig.
    Yoshimura T; Johnson DG
    J Immunol; 1993 Dec; 151(11):6225-36. PubMed ID: 7504015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CXC chemokines bind to unique sets of selectivity determinants that can function independently and are broadly distributed on multiple domains of human interleukin-8 receptor B. Determinants of high affinity binding and receptor activation are distinct.
    Ahuja SK; Lee JC; Murphy PM
    J Biol Chem; 1996 Jan; 271(1):225-32. PubMed ID: 8550564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The CXC chemokine NAP-2 mediates differential heterologous desensitization of neutrophil effector functions elicited by platelet-activating factor.
    Schwartzkopff F; Brandt E; Petersen F; Flad HD; Bock L; Ludwig A
    J Interferon Cytokine Res; 2002 Feb; 22(2):257-67. PubMed ID: 11911809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Connective tissue activation. XXXIII. Biologically active cleavage products of CTAP-III from human platelets.
    Castor CW; Walz DA; Ragsdale CG; Hossler PA; Smith EM; Bignall MC; Aaron BP; Mountjoy K
    Biochem Biophys Res Commun; 1989 Sep; 163(2):1071-8. PubMed ID: 2783111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.